| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.85e-23 | 114 | 152 | 21 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.20e-22 | 124 | 152 | 21 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.07e-21 | 137 | 152 | 21 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.47e-18 | 192 | 152 | 21 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L21 USP17L4 ADAM19 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 PRSS12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 RNPEP USP17L17 USP17L6P USP17L3 C1R USP17L22 USP17L15 USP17L8 | 2.73e-11 | 654 | 152 | 25 | GO:0008233 |
| GeneOntologyMolecularFunction | 3-keto sterol reductase activity | 2.35e-05 | 8 | 152 | 3 | GO:0000253 | |
| GeneOntologyMolecularFunction | carbonyl reductase (NADPH) activity | 3.51e-05 | 9 | 152 | 3 | GO:0004090 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 1.48e-04 | 14 | 152 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 1.84e-04 | 15 | 152 | 3 | GO:0052650 | |
| GeneOntologyMolecularFunction | eukaryotic translation initiation factor 2alpha kinase activity | 8.46e-04 | 6 | 152 | 2 | GO:0004694 | |
| GeneOntologyMolecularFunction | molybdenum ion binding | 8.46e-04 | 6 | 152 | 2 | GO:0030151 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.11e-03 | 27 | 152 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 1.18e-03 | 7 | 152 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.51e-03 | 30 | 152 | 3 | GO:0018455 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.52e-21 | 125 | 149 | 20 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.87e-20 | 144 | 149 | 20 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP17L21 USP17L4 CAND2 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 LRSAM1 USP17L24 USP17L5 PELI2 CUL9 USP17L10 USP17L19 HUWE1 ASB15 USP19 RNF157 USP17L18 CISH UBE4A USP17L17 KLHL15 USP17L6P USP17L3 USP17L22 CTU1 USP17L15 USP17L8 MGRN1 | 1.06e-12 | 1009 | 149 | 32 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP17L21 USP17L4 CAND2 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 LRSAM1 USP17L24 USP17L5 PELI2 CUL9 USP17L10 USP17L19 HUWE1 ASB15 USP19 RNF157 USP17L18 CISH UBE4A USP17L17 KLHL15 USP17L6P USP17L3 USP17L22 CTU1 USP17L15 USP17L8 MGRN1 | 5.56e-12 | 1074 | 149 | 32 | GO:0043687 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 WDR81 USP17L5 USP17L10 USP17L19 USP19 USP17L18 ESYT3 CD1D DHRS4 FAF2 USP17L17 SLC27A1 USP17L6P USP17L3 EMC2 USP17L22 USP17L15 USP17L8 | 1.10e-06 | 1293 | 147 | 26 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 WDR81 USP17L5 USP17L10 USP17L19 USP19 USP17L18 ESYT3 CD1D DHRS4 FAF2 USP17L17 SLC27A1 USP17L6P USP17L3 EMC2 USP17L22 USP17L15 USP17L8 | 1.20e-06 | 1299 | 147 | 26 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 WDR81 USP17L5 USP17L10 USP17L19 USP19 USP17L18 ESYT3 CD1D DHRS4 FAF2 USP17L17 SLC27A1 USP17L6P USP17L3 EMC2 USP17L22 USP17L15 USP17L8 | 1.79e-06 | 1327 | 147 | 26 | GO:0042175 |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 1.18e-25 | 16 | 145 | 13 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 1.18e-25 | 16 | 145 | 13 | IPR006861 |
| Domain | UCH | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 7.76e-23 | 71 | 145 | 18 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 7.76e-23 | 71 | 145 | 18 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 1.03e-22 | 72 | 145 | 18 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 1.03e-22 | 72 | 145 | 18 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 1.03e-22 | 72 | 145 | 18 | IPR001394 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 9.39e-22 | 66 | 145 | 17 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 2.87e-21 | 70 | 145 | 17 | PS00972 |
| Domain | - | PRAMEF7 VASN LRSAM1 CHADL CPN2 PRAMEF8 CD14 CEP78 CIITA SLIT1 LRCH4 XRRA1 LRRN4 FBXL20 | 2.13e-07 | 321 | 145 | 14 | 3.80.10.10 |
| Domain | L_dom-like | PRAMEF7 VASN LRSAM1 CHADL CPN2 PRAMEF8 CD14 CEP78 CIITA SLIT1 LRCH4 XRRA1 LRRN4 FBXL20 | 2.77e-07 | 328 | 145 | 14 | IPR032675 |
| Domain | LRR_1 | VASN LRSAM1 CHADL CPN2 CD14 CIITA SLIT1 LRCH4 XRRA1 LRRN4 FBXL20 | 1.15e-06 | 219 | 145 | 11 | PF00560 |
| Domain | Leu-rich_rpt | VASN LRSAM1 CHADL CPN2 CD14 CEP78 CIITA SLIT1 LRCH4 XRRA1 LRRN4 FBXL20 | 1.39e-06 | 271 | 145 | 12 | IPR001611 |
| Domain | LRR | 2.78e-05 | 201 | 145 | 9 | PS51450 | |
| Domain | LRR_TYP | 7.34e-05 | 177 | 145 | 8 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 7.34e-05 | 177 | 145 | 8 | IPR003591 | |
| Domain | HEAT_REPEAT | 2.12e-04 | 70 | 145 | 5 | PS50077 | |
| Domain | LRR_8 | 3.82e-04 | 171 | 145 | 7 | PF13855 | |
| Domain | HEAT | 5.20e-04 | 48 | 145 | 4 | PF02985 | |
| Domain | Cys-rich_flank_reg_C | 6.81e-04 | 90 | 145 | 5 | IPR000483 | |
| Domain | LRRCT | 6.81e-04 | 90 | 145 | 5 | SM00082 | |
| Domain | HEAT | 1.07e-03 | 58 | 145 | 4 | IPR000357 | |
| Domain | PI3K_Ras-bd_dom | 1.23e-03 | 7 | 145 | 2 | IPR000341 | |
| Domain | PI3K_rbd | 1.23e-03 | 7 | 145 | 2 | SM00144 | |
| Domain | PI3K_rbd | 1.23e-03 | 7 | 145 | 2 | PF00794 | |
| Domain | PI3K_RBD | 1.23e-03 | 7 | 145 | 2 | PS51546 | |
| Domain | ARM-type_fold | 1.34e-03 | 339 | 145 | 9 | IPR016024 | |
| Domain | PI3K_C2 | 1.63e-03 | 8 | 145 | 2 | SM00142 | |
| Domain | PI3K_C2_dom | 1.63e-03 | 8 | 145 | 2 | IPR002420 | |
| Domain | PI3K_C2 | 1.63e-03 | 8 | 145 | 2 | PF00792 | |
| Domain | LAMININ_IVA | 1.63e-03 | 8 | 145 | 2 | PS51115 | |
| Domain | Laminin_B | 1.63e-03 | 8 | 145 | 2 | PF00052 | |
| Domain | PI3K_C2 | 1.63e-03 | 8 | 145 | 2 | PS51547 | |
| Domain | LamB | 1.63e-03 | 8 | 145 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.63e-03 | 8 | 145 | 2 | IPR000034 | |
| Domain | LRRCT | 1.93e-03 | 32 | 145 | 3 | PF01463 | |
| Domain | PI3Ka | 2.08e-03 | 9 | 145 | 2 | PF00613 | |
| Domain | PI3Ka | 2.08e-03 | 9 | 145 | 2 | SM00145 | |
| Domain | - | 2.08e-03 | 9 | 145 | 2 | 1.25.40.70 | |
| Domain | PI_Kinase | 2.59e-03 | 10 | 145 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 2.59e-03 | 10 | 145 | 2 | IPR001263 | |
| Domain | PIK_HELICAL | 2.59e-03 | 10 | 145 | 2 | PS51545 | |
| Domain | UBA | 2.71e-03 | 36 | 145 | 3 | PF00627 | |
| Domain | RWD | 3.14e-03 | 11 | 145 | 2 | PF05773 | |
| Domain | RWD-domain | 3.75e-03 | 12 | 145 | 2 | IPR006575 | |
| Domain | ARM-like | 5.20e-03 | 270 | 145 | 7 | IPR011989 | |
| Domain | SET | 5.45e-03 | 46 | 145 | 3 | SM00317 | |
| Domain | UBA | 5.79e-03 | 47 | 145 | 3 | PS50030 | |
| Domain | PI3/4_kinase_CS | 5.88e-03 | 15 | 145 | 2 | IPR018936 | |
| Domain | - | 5.99e-03 | 148 | 145 | 5 | 2.60.40.150 | |
| Domain | Post-SET_dom | 6.69e-03 | 16 | 145 | 2 | IPR003616 | |
| Domain | PostSET | 6.69e-03 | 16 | 145 | 2 | SM00508 | |
| Domain | - | 6.69e-03 | 16 | 145 | 2 | 1.10.1070.11 | |
| Domain | Laminin_N | 6.69e-03 | 16 | 145 | 2 | IPR008211 | |
| Domain | PI3Kc | 6.69e-03 | 16 | 145 | 2 | SM00146 | |
| Domain | LamNT | 6.69e-03 | 16 | 145 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 6.69e-03 | 16 | 145 | 2 | PS51117 | |
| Domain | Laminin_N | 6.69e-03 | 16 | 145 | 2 | PF00055 | |
| Domain | POST_SET | 6.69e-03 | 16 | 145 | 2 | PS50868 | |
| Domain | SET_dom | 6.88e-03 | 50 | 145 | 3 | IPR001214 | |
| Domain | SET | 6.88e-03 | 50 | 145 | 3 | PS50280 | |
| Domain | LRRNT | 7.17e-03 | 98 | 145 | 4 | IPR000372 | |
| Domain | LRRNT | 7.17e-03 | 98 | 145 | 4 | SM00013 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 3.25e-27 | 45 | 109 | 18 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 3.59e-16 | 191 | 109 | 19 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 | 7.74e-14 | 221 | 109 | 18 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.22e-13 | 262 | 109 | 19 | MM15286 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 RET USP17L18 USP17L17 PIK3CB USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 3.76e-13 | 318 | 109 | 20 | MM15278 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 | 1.33e-11 | 299 | 109 | 18 | M27574 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L4 USP17L2 THSD7A USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 ETFBKMT USP17L5 CUL9 USP17L10 USP17L19 ASB15 USP19 USP17L18 CISH USP17L17 USP17L3 LIPT2 FBXL20 USP17L22 USP17L15 USP17L8 | 1.20e-04 | 1475 | 109 | 25 | M19806 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 USP17L21 USP17L4 USP17L2 THSD7A USP17L12 USP17L1 USP17L20 USP17L11 ETFBKMT USP17L5 USP17L10 USP17L19 USP19 USP17L18 CISH USP17L17 USP17L6P USP17L3 LIPT2 FBXL20 USP17L22 USP17L15 USP17L8 | 1.26e-04 | 1389 | 109 | 24 | MM15307 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.01e-40 | 21 | 154 | 18 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.01e-40 | 21 | 154 | 18 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.01e-40 | 21 | 154 | 18 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.01e-40 | 21 | 154 | 18 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.01e-40 | 21 | 154 | 18 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.01e-40 | 21 | 154 | 18 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.10e-39 | 22 | 154 | 18 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.01e-38 | 24 | 154 | 18 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 7.17e-38 | 25 | 154 | 18 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.32e-37 | 26 | 154 | 18 | 35816173 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.65e-37 | 33 | 154 | 19 | 20228807 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 17109758 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 20368735 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-36 | 34 | 154 | 19 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.29e-36 | 35 | 154 | 19 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.29e-36 | 35 | 154 | 19 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.83e-36 | 36 | 154 | 19 | 20147298 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 5.08e-36 | 29 | 154 | 18 | 32527007 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 9.90e-36 | 37 | 154 | 19 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 PRAMEF7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 PRAMEF8 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 9.81e-35 | 50 | 154 | 20 | 31806660 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 5.49e-18 | 10 | 154 | 8 | 24207026 |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 6.00e-17 | 12 | 154 | 8 | 24695638 | |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 3.61e-16 | 14 | 154 | 8 | 11793228 |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 8.92e-15 | 19 | 154 | 8 | 28067227 |
| Pubmed | USP17L7 PRAMEF7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 PRAMEF8 TNFRSF21 USP17L18 USP17L17 USP17L6P USP17L3 MAP7D2 USP17L22 USP17L15 USP17L8 | 3.37e-13 | 674 | 154 | 22 | 37196079 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP19 USP17L6P USP17L3 USP17L15 USP17L8 | 1.03e-10 | 81 | 154 | 9 | 12838346 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 27323117 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 10333503 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 20525226 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 12680773 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 16406282 | ||
| Pubmed | Molecular and functional evolution of human DHRS2 and DHRS4 duplicated genes. | 3.39e-07 | 4 | 154 | 3 | 23036705 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17 | 1.08e-06 | 119 | 154 | 7 | 28625976 |
| Pubmed | 2.34e-06 | 48 | 154 | 5 | 16421571 | ||
| Pubmed | CUL9 URB2 SNX19 USP19 RNF157 FAF2 BAZ2A SLIT1 SEL1L3 MAPKBP1 | 1.48e-05 | 407 | 154 | 10 | 12693553 | |
| Pubmed | 1.86e-05 | 332 | 154 | 9 | 37433992 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 15623156 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 21478404 | ||
| Pubmed | Alternative transcription initiation and splicing variants of the DHRS4 gene cluster. | 1.95e-05 | 2 | 154 | 2 | 18754758 | |
| Pubmed | MHC class II-expressing thymocytes suppress invariant NKT cell development. | 1.95e-05 | 2 | 154 | 2 | 18982019 | |
| Pubmed | The relationship between expressions of the laminin gene and RET gene in Hirschsprung's disease. | 1.95e-05 | 2 | 154 | 2 | 18661771 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 15473316 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 1684419 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17230527 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 20400461 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 32360594 | ||
| Pubmed | Brain ischemia and reperfusion activates the eukaryotic initiation factor 2alpha kinase, PERK. | 5.83e-05 | 3 | 154 | 2 | 11389192 | |
| Pubmed | Effect of transporter and DNA repair gene polymorphisms to lung cancer chemotherapy toxicity. | 5.83e-05 | 3 | 154 | 2 | 26358256 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 22495427 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 22891334 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 32329716 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 37429610 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 19500084 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 23443115 | ||
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | 1.12e-04 | 419 | 154 | 9 | 28700943 | |
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 23943651 | ||
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 1.16e-04 | 4 | 154 | 2 | 22984479 | |
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 8621488 | ||
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 28486105 | ||
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 7579515 | ||
| Pubmed | Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. | 1.16e-04 | 4 | 154 | 2 | 18594509 | |
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 34436957 | ||
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 18677106 | ||
| Pubmed | Integrated stress response of vertebrates is regulated by four eIF2α kinases. | 1.16e-04 | 4 | 154 | 2 | 27633668 | |
| Pubmed | Renal collecting system growth and function depend upon embryonic γ1 laminin expression. | 1.41e-04 | 23 | 154 | 3 | 21903675 | |
| Pubmed | DHX57 RGS3 SYDE1 CEP78 DDHD1 LRCH4 PLCB3 EIF2AK4 PZP MOCOS MGRN1 | 1.61e-04 | 650 | 154 | 11 | 38777146 | |
| Pubmed | A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system. | 1.87e-04 | 118 | 154 | 5 | 19690564 | |
| Pubmed | 1.93e-04 | 5 | 154 | 2 | 9454853 | ||
| Pubmed | Analysis of mouse Evx genes: Evx-1 displays graded expression in the primitive streak. | 1.93e-04 | 5 | 154 | 2 | 1349539 | |
| Pubmed | 1.93e-04 | 5 | 154 | 2 | 23701859 | ||
| Pubmed | Mechanisms governing B cell developmental defects in invariant chain-deficient mice. | 1.93e-04 | 5 | 154 | 2 | 14764672 | |
| Pubmed | Regulation of neuronal survival and morphology by the E3 ubiquitin ligase RNF157. | 1.93e-04 | 5 | 154 | 2 | 25342469 | |
| Pubmed | A Membrane-Tethered Ubiquitination Pathway Regulates Hedgehog Signaling and Heart Development. | 1.93e-04 | 5 | 154 | 2 | 32966817 | |
| Pubmed | 1.93e-04 | 5 | 154 | 2 | 14557411 | ||
| Pubmed | 2.05e-04 | 26 | 154 | 3 | 24742657 | ||
| Pubmed | Alternatively spliced isoforms of WT1 control podocyte-specific gene expression. | 2.57e-04 | 28 | 154 | 3 | 25993318 | |
| Pubmed | Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases. | 2.89e-04 | 6 | 154 | 2 | 24019522 | |
| Pubmed | RET finger protein enhances MBD2- and MBD4-dependent transcriptional repression. | 2.89e-04 | 6 | 154 | 2 | 17049487 | |
| Pubmed | 2.89e-04 | 6 | 154 | 2 | 26572137 | ||
| Pubmed | 4.03e-04 | 7 | 154 | 2 | 29093530 | ||
| Pubmed | ATF4 Regulates CD4+ T Cell Immune Responses through Metabolic Reprogramming. | 4.03e-04 | 7 | 154 | 2 | 29742431 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MPP3 ANKS6 KAT6A NSD1 CUL9 LAMC3 HUWE1 TEP1 TNFRSF21 SLC2A1 PIK3C2B NAPRT MAPKBP1 TBCD | 4.20e-04 | 1105 | 154 | 14 | 35748872 |
| Pubmed | 4.21e-04 | 33 | 154 | 3 | 30917309 | ||
| Pubmed | 4.35e-04 | 504 | 154 | 9 | 34432599 | ||
| Pubmed | 4.53e-04 | 143 | 154 | 5 | 22516433 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | USP17L7 IPPK USP17L12 LAMA1 PCARE HUWE1 STOX1 XRCC5 EXOC3L4 USP17L3 PLCB3 | 4.62e-04 | 736 | 154 | 11 | 29676528 |
| Pubmed | 5.02e-04 | 35 | 154 | 3 | 19389355 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 5.14e-04 | 313 | 154 | 7 | 38270169 | |
| Pubmed | 5.36e-04 | 8 | 154 | 2 | 8812145 | ||
| Pubmed | 5.36e-04 | 8 | 154 | 2 | 24356957 | ||
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 6.24e-04 | 233 | 154 | 6 | 32290105 | |
| Cytoband | 4p16.1 | USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 | 1.29e-20 | 79 | 154 | 14 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 | 3.67e-14 | 222 | 154 | 14 | chr4p16 |
| Cytoband | 8p23.1 | 1.44e-05 | 154 | 154 | 6 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 1.47e-04 | 234 | 154 | 6 | chr8p23 | |
| Cytoband | 7q31.31 | 1.66e-04 | 6 | 154 | 2 | 7q31.31 | |
| Cytoband | 14q11.2 | 3.70e-04 | 180 | 154 | 5 | 14q11.2 | |
| Cytoband | 14q21 | 4.94e-04 | 10 | 154 | 2 | 14q21 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.66e-23 | 86 | 150 | 18 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.72e-21 | 112 | 150 | 18 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 XDH USP17L10 USP17L19 USP17L18 CD1D USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.81e-21 | 160 | 150 | 20 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 VASN USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 PLEKHG6 RNPEP USP17L17 SLC27A1 USP17L6P USP17L3 MAPKBP1 FBXL20 USP17L22 USP17L15 USP17L8 | 3.63e-13 | 647 | 150 | 24 | MM981 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 VASN USP17L11 USP17L5 USP17L10 USP17L19 LTB4R2 USP17L18 USP17L17 EXOC3L4 USP17L6P USP17L3 ETNK1 MRNIP CTF1 EMC2 USP17L22 CTU1 USP17L15 TBCD USP17L8 MOCOS | 1.96e-10 | 1198 | 150 | 28 | MM1062 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 IPPK USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 VASN USP17L11 USP17L5 USP17L10 USP17L19 TNFRSF21 USP17L18 PLEKHG6 CD14 RNPEP USP17L17 SLC27A1 USP17L6P USP17L3 PLCB3 MAPKBP1 FBXL20 USP17L22 USP17L15 USP17L8 | 3.31e-10 | 1226 | 150 | 28 | MM979 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 RGS3 SLC2A1 USP17L18 CISH USP17L17 USP17L6P USP17L3 RPUSD2 USP17L22 USP17L15 USP17L8 | 2.09e-07 | 1072 | 150 | 22 | MM1031 |
| Coexpression | WANG_MLL_TARGETS | 5.19e-05 | 294 | 150 | 9 | M2456 | |
| Coexpression | WANG_MLL_TARGETS | 7.06e-05 | 306 | 150 | 9 | MM1076 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.29e-08 | 191 | 144 | 9 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.26e-06 | 183 | 144 | 7 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.42e-06 | 185 | 144 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | normal_Lung-Myeloid_cells-Pleural_Mac|normal_Lung / Location, Cell class and cell subclass | 1.32e-05 | 159 | 144 | 6 | f95a5570bf153fc5c598aba855db6b47ba818463 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-pDC|Liver / Manually curated celltypes from each tissue | 1.69e-05 | 166 | 144 | 6 | 24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 179 | 144 | 6 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 179 | 144 | 6 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 179 | 144 | 6 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.20e-05 | 186 | 144 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 3.20e-05 | 186 | 144 | 6 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue | 3.30e-05 | 187 | 144 | 6 | 9f3db9f0e5de34aeabfe5984f675bc7a65435df7 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.30e-05 | 187 | 144 | 6 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.30e-05 | 187 | 144 | 6 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue | 3.40e-05 | 188 | 144 | 6 | 239a2162a21d3339da7c1884ab76286346fbf97f | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 4.28e-05 | 196 | 144 | 6 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 144 | 6 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 144 | 6 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 144 | 6 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 144 | 6 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.79e-05 | 200 | 144 | 6 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.72e-32 | 46 | 146 | 19 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.74e-28 | 69 | 146 | 19 | DOID:1682 (implicated_via_orthology) |
| Disease | Hereditary xanthinuria | 2.43e-05 | 2 | 146 | 2 | cv:C5779508 | |
| Disease | Nephronophthisis, familial juvenile | 5.02e-04 | 7 | 146 | 2 | C1855681 | |
| Disease | microcephaly (implicated_via_orthology) | 5.30e-04 | 32 | 146 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | basal cell carcinoma (is_marker_for) | 6.68e-04 | 8 | 146 | 2 | DOID:2513 (is_marker_for) | |
| Disease | Congenital Hydrocephalus | 6.68e-04 | 8 | 146 | 2 | C0020256 | |
| Disease | Developmental Coordination Disorder | 6.68e-04 | 8 | 146 | 2 | C0011757 | |
| Disease | Motor Skills Disorders | 6.68e-04 | 8 | 146 | 2 | C0026613 | |
| Disease | response to anti-thyroid drug, Drug-induced agranulocytosis | 6.68e-04 | 8 | 146 | 2 | EFO_0007838, HP_0012235 | |
| Disease | Autism Spectrum Disorders | 8.54e-04 | 85 | 146 | 4 | C1510586 | |
| Disease | Gout | 8.56e-04 | 9 | 146 | 2 | C0018099 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 1.30e-03 | 11 | 146 | 2 | C1335302 | |
| Disease | chronic musculoskeletal pain | 1.55e-03 | 12 | 146 | 2 | EFO_0022195 | |
| Disease | fructose measurement, glucose measurement, galactose measurement | 1.55e-03 | 12 | 146 | 2 | EFO_0004468, EFO_0010477, EFO_0010481 | |
| Disease | polyp of colon | 2.72e-03 | 56 | 146 | 3 | MONDO_0021400 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.82e-03 | 128 | 146 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.82e-03 | 128 | 146 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.82e-03 | 128 | 146 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.82e-03 | 128 | 146 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.82e-03 | 128 | 146 | 4 | C0007134 | |
| Disease | non-word reading | 4.51e-03 | 67 | 146 | 3 | EFO_0005299 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VICRPAAEALRQPVL | 476 | Q14146 | |
| CIEPDVQFLRASLQP | 1481 | Q14146 | |
| GLQRELQPLFRVVCT | 521 | Q17RC7 | |
| LVVFLESACNLPRNP | 446 | A0FGR9 | |
| ELPPQVFSQLFCLER | 231 | P22792 | |
| FPQPCRAAERLQVLL | 126 | Q9H4A4 | |
| ALPPLLDAVCRRQAE | 96 | Q16619 | |
| VQLCTPLLLPRNRQI | 1081 | Q9P2K8 | |
| GLCQIVRRFPELQLP | 196 | A4D0V7 | |
| CLLAFALQPLRPRAA | 11 | Q9H013 | |
| SFNLNAINRCPLPRP | 281 | P09972 | |
| RFLAGLIFQPPARCL | 756 | P33076 | |
| EPALCDRLRTQPFQA | 951 | Q9UIF9 | |
| PRRCELAAALNLPET | 211 | P49640 | |
| PRRCELAAALNLPET | 216 | Q03828 | |
| ALCPERFVPLSAQNR | 31 | Q8WXK1 | |
| PNLDPLNCLLVAVRA | 376 | Q8WXK1 | |
| IGNERFRCPETLFQP | 251 | P63267 | |
| AFQICCLLLPPENRR | 311 | Q8WUY9 | |
| INHLCDPNIIPVRVF | 1111 | Q96KQ7 | |
| INRLVADVDCLPLPR | 231 | Q9NSE2 | |
| QNSVPLPAVRACLRE | 26 | Q5JTW2 | |
| ICFPRPRSAQQPVLF | 56 | A6NGY3 | |
| LAIELAPRNIRVNCL | 196 | Q9BTZ2 | |
| DLRFVRLPVANPQAC | 606 | P00736 | |
| PVTNPIVRNALFCLE | 1121 | P20742 | |
| ELPRRNCLLPFSNPV | 6 | Q96L73 | |
| VLILRLPFCGPNQLD | 161 | A0A096LPK9 | |
| FVQPLDLCNPARTLL | 556 | P49796 | |
| AQRCVVLRFLKFPPN | 26 | Q9H8X2 | |
| SRNRFPEVPEAACQL | 76 | O75427 | |
| CQLANQLRPRSVPFI | 571 | O75427 | |
| AQNPRPTRLCDLFIT | 321 | Q6NTE8 | |
| PNLLSAERLQFCPQR | 226 | C9J442 | |
| LAIELAPRNIRVNCL | 196 | Q6PKH6 | |
| LQQAAIPLLPKRFCE | 781 | P56730 | |
| QQLLERFSLPPQCRV | 196 | Q92813 | |
| IRQCPEVFPLLQEAR | 281 | Q8WZ60 | |
| LPVVNFGSPLRRCEF | 266 | Q96T17 | |
| QVRLSPPFLECQEGR | 226 | Q6PRD1 | |
| FCPESPRFLLINRNE | 206 | P11166 | |
| QPLRTCPLCRQDIAQ | 701 | Q6UWE0 | |
| IELAPRNIRVNCLAP | 201 | P0CG22 | |
| NNCPICRLPFRALLQ | 311 | O60291 | |
| FLDPRQRQQNIRPLC | 331 | Q5VW00 | |
| VLILRLPFCGPNQLD | 161 | Q8NGD1 | |
| VLILRLPFCGPNQLD | 161 | Q8N0Y3 | |
| LAIRIPLNDLFRCNS | 141 | P13473 | |
| EPRLCLIQPFIDLRQ | 631 | Q96EN8 | |
| FPAVTLCNINPLRRS | 86 | Q9UHC3 | |
| RLCQAFGPRLIQLDD | 161 | O15527 | |
| LRVLGPAACRNPDIF | 1871 | Q7Z6Z7 | |
| NVCNIPFLGALFRRL | 111 | Q6ZVE7 | |
| CFPVQVNRLPRETLL | 691 | O00750 | |
| CPRDTRIVQLVFPAL | 36 | Q9BPV8 | |
| RNEANQPLCLPALLI | 826 | Q01970 | |
| LVCQPLRDPNSFLLI | 461 | Q3KR16 | |
| QLNLRPVDVDPECLR | 761 | Q92794 | |
| CPQIINAALALAARP | 456 | Q9UI47 | |
| VLDLSCNRLNRAPQP | 301 | P08571 | |
| FPQICLDLPRNLTAN | 1491 | Q4G0P3 | |
| PLRPDCLAIVNNFVF | 316 | Q96M94 | |
| EPNPLRSRQVFKLLC | 81 | Q9BQI3 | |
| VPQRLFPLRCLQISS | 21 | P15813 | |
| IPVAACTFDVRNLLP | 261 | Q9BVV2 | |
| LPEIQRVPLEQLCLR | 991 | Q6P158 | |
| ALPRCRPLQFASQKE | 206 | Q7Z7A3 | |
| LPPAFQLLLRACDQG | 6 | Q68DC2 | |
| VRDLCRVLQLPPTFE | 76 | Q9HAW0 | |
| QQAASVLLPRCRLNP | 1161 | O60336 | |
| AVLEQIGLCFPNRLP | 1616 | Q8IWT3 | |
| FNLLSRCLEPLPQEQ | 1231 | Q9H583 | |
| LALFCLQELRRQFPG | 71 | Q15006 | |
| REQFGPLPQLAAVCR | 31 | Q6QHK4 | |
| LPREICNRLLNIFHP | 646 | Q8NEL9 | |
| LNCELNRLNPFPILI | 156 | Q8IXQ9 | |
| VCNPAIFRLIARQLA | 221 | Q9HBU6 | |
| LRVDPANFPLLIQCF | 91 | Q6B0K9 | |
| LLAPARQAAAQRCPQ | 21 | Q6NUI6 | |
| PCILDFQSRNVIPDI | 111 | Q9BQA5 | |
| ATLCPAPVLQRVDRL | 1136 | O75155 | |
| VLFNIRASACIPPDN | 236 | Q5VWM4 | |
| PCTQLQLLNPERFAR | 731 | Q9NZJ4 | |
| QLFPLFIRLVSDPCR | 241 | Q9P1A2 | |
| KRCLVQVAFRPVLPE | 1096 | Q9C0B2 | |
| LCELQGLQDARARPP | 126 | A6NK58 | |
| LQPRAFACFPALQLL | 161 | Q8WUT4 | |
| QRRAALCALNPLPFL | 1176 | A6NGG8 | |
| PCQEAGLPFQRRQVL | 246 | Q13368 | |
| AEQPGRDCRFLVLPQ | 81 | O14926 | |
| VQLFPCLSPLLLDAR | 186 | Q6KF10 | |
| ECRLVRQDPLPQDLV | 501 | Q8IZ73 | |
| QNLAVCFGPVLLPAR | 551 | Q6ZW31 | |
| RIPQCPLENDVVALL | 236 | Q68CR1 | |
| NCPICRLPFRALLQI | 311 | Q96PX1 | |
| LRQVRLDPCDLQPIF | 586 | O75509 | |
| VDRQLCRDAIFPIPV | 611 | Q9UPZ6 | |
| VCGFILEPRLLIQQR | 706 | Q969F9 | |
| SLQRCLAVTRPFLAP | 116 | Q9NPC1 | |
| IPLCTFQRQPRAAPV | 26 | P57071 | |
| EALRQEINAARPQCP | 271 | Q9HAT8 | |
| NALGQNCPRLRILEV | 266 | Q96IG2 | |
| QCRQRGLFPAILNLA | 16 | P25391 | |
| FQIEANFPRRVLPCI | 401 | Q96CS3 | |
| ECLAALPRPQLRSVV | 71 | Q9UHJ6 | |
| ALAQPTLRCAAAPLR | 196 | Q66K80 | |
| LRQDCREIFPQSLPK | 561 | P42338 | |
| IFINLLQQICRAPEP | 276 | Q7Z745 | |
| NEIRRVFCDIPPLLA | 211 | Q8NGG2 | |
| ERLPLHVRFLENCQP | 1486 | Q9Y566 | |
| ILPICQDQDFLPRDQ | 576 | Q0P6D6 | |
| RVLNCFTLPLPAQAV | 186 | Q96JI7 | |
| VLFNIRASACIPPDN | 236 | Q5VXH5 | |
| LCDDLAPVARQLAPR | 51 | A6NCW0 | |
| GPRFLISDRDPQCNL | 31 | Q9H4F8 | |
| DQCLNLFTRPEVLAP | 1061 | O94966 | |
| QLPAVRQLLPCARVQ | 301 | Q86XI8 | |
| LRPFIQCKLLAQPAE | 2851 | Q8N2C7 | |
| LCDDLAPVARQLAPR | 51 | A6NCW7 | |
| NNILAIAAFLPACRP | 306 | Q99973 | |
| ALLNVNLRREPLAFC | 156 | Q6PCB7 | |
| LLVRAPPACLQVLRD | 71 | Q6ZVD7 | |
| LCDDLAPVARQLAPR | 51 | D6R9N7 | |
| LCDDLAPVARQLAPR | 51 | A8MUK1 | |
| GESLLEAQPRPFRCN | 1041 | O15015 | |
| LCDDLAPVARQLAPR | 51 | D6R901 | |
| LCDDLAPVARQLAPR | 51 | D6RCP7 | |
| IPIEFRVSLLRDCPN | 1236 | P47989 | |
| RPAQVEPLLRLCLQQ | 466 | Q6XQN6 | |
| LCDDLAPVARQLAPR | 51 | Q7RTZ2 | |
| FLQPNVRGPLFLCED | 356 | Q92543 | |
| RLLAAARNPFNCVCP | 291 | Q6EMK4 | |
| HQFRLLPVQFLCPNI | 186 | P07949 | |
| LCDDLAPVARQLAPR | 51 | C9JPN9 | |
| LCDDLAPVARQLAPR | 51 | Q0WX57 | |
| VEEFPLRCPLFAQQR | 176 | Q16587 | |
| LCDDLAPVARQLAPR | 51 | P0C7H9 | |
| LCDDLAPVARQLAPR | 51 | P0C7I0 | |
| DPLTECANFVRVLQP | 111 | Q9NS98 | |
| FPGDVRRQALLQLCL | 1101 | Q9BTW9 | |
| VPENLLPFAVQCRNL | 191 | Q14139 | |
| LCDDLAPVARQLAPR | 51 | Q6QN14 | |
| AARVPPRDLAVLLCN | 6 | O15050 | |
| QARPRLLLPVQSLVC | 281 | Q8TD22 | |
| LCDDLAPVARQLAPR | 51 | D6RA61 | |
| QCIPPLAFQGLRSLR | 821 | O75093 | |
| LCDDLAPVARQLAPR | 51 | C9J2P7 | |
| LCDDLAPVARQLAPR | 51 | D6RBQ6 | |
| LNNCFPARNLLRVPE | 16 | Q6P2D8 | |
| LCDDLAPVARQLAPR | 51 | D6RBM5 | |
| RVQPAVPLQCLLHRD | 756 | Q562E7 | |
| LCDDLAPVARQLAPR | 51 | Q6R6M4 | |
| KIPNPRFQRLFQCLL | 481 | P13010 | |
| LCDDLAPVARQLAPR | 51 | D6RJB6 | |
| LCDDLAPVARQLAPR | 51 | C9JJH3 | |
| LCDDLAPVARQLAPR | 51 | C9JVI0 | |
| RPQRCLPVFENAAFG | 31 | Q9Y6N6 | |
| AAPQIPARAFRVVCD | 621 | Q8N9H8 |